共 50 条
- [35] Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Alirocumab in Healthy Chinese Subjects: A Randomized, Double-Blind, Placebo-Controlled, Ascending Single-Dose Study American Journal of Cardiovascular Drugs, 2020, 20 : 489 - 503
- [37] Phase 2, double-blind, randomized, placebo-controlled study of the safety and efficacy of elagolix in women with polycystic ovary syndrome F&S REPORTS, 2023, 4 (02): : 206 - 212